CAS：2156-56-1
MF：C2H3Cl2NaO2
MW：152.93
EINECS: 218-461-3
Storage conditions: Inert atmosphere, 2-8 ° C
What is of Sodium Dichloroacetate with cas 2156-56-1?
Sodium dichloroacetate (DCA) is a mitochondrial pyruvate dehydrogenase kinase inhibitor, and is an orally absorbable small molecular compound for MELAS syndrome, and children with congenital lactic acidosis and other diseases that are treated in the clinic. Recent studies had found that DCA acts as a potential vasoprotective agent by inhibiting PDK2 and reducing coronary endarterium proliferation. Further, DCA promotes brain regeneration after cerebral ischemia, which indicates that DCA might play an important role in VD.
Specification
|
Item
|
Specifications
|
Results
|
|
|
Appearance
|
White powder or crystalline powder
|
Confirms
|
|
|
Purity , %
|
≥99.5
|
99.99
|
|
|
Melting point range , ℃
|
64.0~67.0
|
Confirms
|
|
|
Loss on drying , %
|
≤0.5
|
0.030
|
|
|
Moisture , %
|
≤0.5
|
0.047
|
|
Usage
Sodium dichloroacetate is an inhibitor of mitochondrial pyruvate dehydrogenase kinase.
Packing
25kgs/drum, 9tons/20’container
